Trial Profile
A Phase 1, Single Center, Randomized (2-Sequence), Single Blind, 3-Period Study Comparing the Safety, Tolerability, and Pharmacokinetics of Ecopipam Controlled Release Capsules With Ecopipam HCl Immediate Release Tablets in Male Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Ecopipam (Primary)
- Indications Gambling; Gilles de la Tourette's syndrome; Lesch-Nyhan syndrome
- Focus Adverse reactions
- 06 Aug 2013 New trial record